Roche's Genentech Names Alexander Hardy Chief Executive

Date : 01/24/2019 @ 4:25PM
Source : Dow Jones News
Stock : Roche Holding (QX) (RHHBY)
Quote : 38.05  -0.18 (-0.47%) @ 3:50PM

Roche's Genentech Names Alexander Hardy Chief Executive

Roche Holding (QX) (USOTC:RHHBY)
Historical Stock Chart

1 Year : From Nov 2018 to Nov 2019

Click Here for more Roche Holding (QX) Charts.

By Michael Dabaie


Roche Holding AG's (RHHBY) Genentech on Thursday named Alexander Hardy chief executive effective March 1.

Mr. Hardy succeeds Bill Anderson, who was recently appointed chief executive of Roche Pharmaceuticals. Roche last month said it appointed Mr. Anderson CEO of Roche Pharmaceuticals, replacing Daniel O'Day, who was named chief executive of Gilead Sciences Inc. (GILD).

Mr. Hardy first joined Genentech in 2005, where he held several senior management positions. In 2014, he became head of Asia Pacific for Roche Pharmaceuticals and is currently head of global product strategy.


Write to Michael Dabaie at


(END) Dow Jones Newswires

January 24, 2019 11:10 ET (16:10 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.